Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherFOCUS ON MOLECULAR IMAGING

Antibodies and Antimatter: The Resurgence of Immuno-PET

Anna M. Wu
Journal of Nuclear Medicine January 2009, 50 (1) 2-5; DOI: https://doi.org/10.2967/jnumed.108.056887
Anna M. Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 50 no. 1 2-5
DOI 
https://doi.org/10.2967/jnumed.108.056887
PubMed 
19091888

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 12, 2008
  • Accepted for publication October 21, 2008
  • Published online January 12, 2009.

Article Versions

  • previous version (December 17, 2008 - 06:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Anna M. Wu
  1. David Geffen School of Medicine at UCLA
    Los Angeles, California
  1. For correspondence or reprints contact: Anna M. Wu, Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095-1770. E-mail: awu{at}mednet.ucla.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 153 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2008 to April 2025

AbstractFullPdf
Dec 200813017
Jan 200918065198
Feb 2009585482
Mar 2009674860
Apr 2009414452
May 2009403233
Jun 2009332539
Jul 2009242124
Aug 2009271220
Sep 2009203529
Oct 2009431232
Nov 2009283932
Dec 2009143125
Jan 2010194536
Feb 2010173128
Mar 2010143934
Apr 2010254834
May 2010195339
Jun 2010175229
Jul 2010224132
Aug 2010465639
Sep 2010145927
Oct 2010203624
Nov 2010275435
Dec 2010193529
Jan 2011173624
Feb 2011165035
Mar 2011214539
Apr 2011183430
May 2011171931
Jun 2011304525
Jul 2011217521
Aug 2011432127
Sep 2011242546
Oct 2011395429
Nov 2011434536
Dec 2011362419
Jan 2012254433
Feb 2012433222
Mar 2012403932
Apr 2012364233
May 2012353135
Jun 2012291938
Jul 2012373654
Aug 2012192235
Sep 2012252828
Oct 2012312639
Nov 20124429501
Dec 2012722326
Jan 2013342736
Feb 2013464434
Mar 2013283029
Apr 2013391335
May 2013453339
Jun 2013312023
Jul 201317917
Aug 2013251326
Sep 2013121120
Oct 2013241718
Nov 201322927
Dec 2013221025
Jan 201416715
Feb 2014201235
Mar 2014161129
Apr 2014131123
May 201420613
Jun 2014252723
Jul 2014202526
Aug 2014111914
Sep 2014212611
Oct 2014332722
Nov 2014171516
Dec 201413186
Jan 2015181910
Feb 2015282212
Mar 2015302817
Apr 2015212111
May 201523215
Jun 2015252110
Jul 2015133018
Aug 2015241918
Sep 2015262113
Oct 201510317
Nov 2015344221
Dec 2015454219
Jan 2016373221
Feb 2016262117
Mar 2016151420
Apr 2016332316
May 201622257
Jun 2016273814
Jul 2016252410
Aug 2016192110
Sep 2016192516
Oct 2016362033
Nov 2016332312
Dec 2016251376
Jan 20171533615
Feb 20171819615
Mar 20172235320
Apr 20171145011
May 2017162649
Jun 2017118210
Jul 201713334
Aug 201725226
Sep 2017151618
Oct 2017332717
Nov 2017212916
Dec 201715318
Jan 2018152212
Feb 2018161611
Mar 201815915
Apr 2018281314
May 2018351620
Jun 2018331614
Jul 2018132111
Aug 20188158
Sep 201883615
Oct 2018161819
Nov 2018121219
Dec 2018101719
Jan 201991514
Feb 2019261722
Mar 2019412634
Apr 2019277333
May 2019201218
Jun 201914915
Jul 2019231919
Aug 2019231320
Sep 201910612
Oct 2019161016
Nov 201917813
Dec 201917415
Jan 20201086
Feb 2020838
Mar 20201318
Apr 2020191423
May 202011127
Jun 2020739
Jul 20208511
Aug 2020736
Sep 20201337
Oct 202010269
Nov 202023129
Dec 2020121710
Jan 202191710
Feb 2021104416
Mar 2021192821
Apr 20215215
May 2021205232
Jun 202163211
Jul 202121912
Aug 202161718
Sep 2021122210
Oct 202153728
Nov 2021192243
Dec 202163214
Jan 202262217
Feb 202272619
Mar 202252616
Apr 202263310
May 202282327
Jun 20223259
Jul 20223314
Aug 20224218
Sep 202272625
Oct 202232215
Nov 20226219
Dec 202283213
Jan 2023118119
Feb 202343812
Mar 202344216
Apr 202349220
May 202382018
Jun 20234308
Jul 202353023
Aug 20233229
Sep 20233269
Oct 2023103613
Nov 202335516
Dec 20236926
Jan 2024144210
Feb 20243308
Mar 20244147
Apr 2024253814
May 202493922
Jun 202444317
Jul 2024105821
Aug 202486420
Sep 202445414
Oct 2024103211
Nov 202432213
Dec 202464116
Jan 202573712
Feb 2025109112
Mar 2025827010
Apr 2025937927
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (1)
Journal of Nuclear Medicine
Vol. 50, Issue 1
January 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antibodies and Antimatter: The Resurgence of Immuno-PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Antibodies and Antimatter: The Resurgence of Immuno-PET
Anna M. Wu
Journal of Nuclear Medicine Jan 2009, 50 (1) 2-5; DOI: 10.2967/jnumed.108.056887

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antibodies and Antimatter: The Resurgence of Immuno-PET
Anna M. Wu
Journal of Nuclear Medicine Jan 2009, 50 (1) 2-5; DOI: 10.2967/jnumed.108.056887
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • ANTIBODIES—EXPANDING APPLICATIONS IN IMAGING
    • SOURCES OF ANTIBODIES FOR MOLECULAR IMAGING
    • ENGINEERED ANTIBODY FRAGMENTS FOR OPTIMIZING PHARMACOKINETICS
    • ANTIMATTER—PROGRESS WITH POSITRON-EMITTING RADIONUCLIDES
    • CONCLUSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Preclinical PET imaging with the novel human antibody 89Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues
  • The Impact of Fc{gamma}RI Binding on Immuno-PET
  • Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors
  • Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody
  • Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
  • Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
  • First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
  • Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging
  • Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
  • An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
  • Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
  • PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
  • Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma
  • Anti-MET ImmunoPET for Non-Small Cell Lung Cancer Using Novel Fully Human Antibody Fragments
  • Improved Modeling of In Vivo Kinetics of Slowly Diffusing Radiotracers for Tumor Imaging
  • Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET
  • Multicenter Harmonization of 89Zr PET/CT Performance
  • Effective dose to staff members in a positron emission tomography/CT facility using zirconium-89
  • A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry
  • Immuno-PET of Tissue Factor in Pancreatic Cancer
  • Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
  • Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT
  • Google Scholar

More in this TOC Section

  • From Genome to Phenome: Opportunities and Challenges of Molecular Imaging
  • Imaging the Activity of Efflux Transporters at the Blood–Brain Barrier in Neurologic Diseases: Radiotracer Selection Criteria
  • Molecular Imaging of Pulmonary Fibrosis
Show more Focus on Molecular Imaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire